Archive for the ‘Drug Recalls & Safety Notices’ category

FDA authorizes first direct-to-consumer test for detecting genetic variants that may be associated with medication metabolism

October 31, 2018

FDA authorizes first direct-to-consumer test for detecting genetic variants that may be associated with medication metabolism

Statement from FDA Commissioner Scott Gottlieb, M.D., on meetings with industry related to the agency’s ongoing policy commitment to firmly address rising epidemic rates in youth e-cigarette use

October 31, 2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on meetings with industry related to the agency’s ongoing policy commitment to firmly address rising epidemic rates in youth e-cigarette use.

FDA takes action to stop the use of lead acetate in hair dyes

October 30, 2018

FDA takes action to stop the use of lead acetate in hair dyes. FDA will no longer allow lead acetate to be used in certain hair coloring products based on data that demonstrate that there is no longer a reasonable certainty of no harm from the use of this color additive.

Statement from FDA Commissioner Scott Gottlieb, M.D., and Deputy Commissioner Anna Abram on the FDA’s new plan to advance plant, animal biotechnology innovation

October 30, 2018

FDA announces new plan to advance the development of plant and animal biotechnology innovation

Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s new consideration of labeling for sesame allergies

October 29, 2018

Food allergies have touched the lives of most of us. Thousands of Americans experience life-threatening, food-related reactions each year, and an estimated 20 people die from them annually. In some cases, such reactions occur despite a careful reading of packaged food labels by conscientious consumers. To me, that’s unacceptable. The FDA is committed to advancing […]

FDA permits marketing of a diagnostic test to aid in the determination of menopausal status

October 24, 2018

FDA permits marketing of a diagnostic test to aid in the determination of menopausal status

Statement from FDA Commissioner Scott Gottlieb, M.D., on how new regulatory authorities will assist the agency in more forcefully addressing opioid crisis; included as part of the newly enacted Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act

October 24, 2018

The SUPPORT Act grants FDA additional authorities to meaningfully advance efforts to combat the crisis of opioid addiction plaguing our nation.

FDA approves new drug to treat influenza

October 24, 2018

FDA approved Xofluza (baloxavir marboxil) to treat acute uncomplicated flu in patients 12 years old and older who have been symptomatic for less than 48 hours.

Federal judge enters consent decree against Tennessee over-the-counter drug manufacturer

October 23, 2018

A federal court orders a Tennessee-based company to stop selling over-the-counter (OTC) drug products

FDA launches global operation to crack down on websites selling illegal, potentially dangerous drugs; including opioids

October 23, 2018

FDA warns website networks as part of global crack down for selling illegal pharmaceuticals

Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s efforts to advance new ways to increase the availability of naloxone as one means for reducing opioid overdose deaths

October 23, 2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s efforts to advance new ways to increase the availability of naloxone as one means for reducing opioid overdose deaths

Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s ongoing commitment to improving efficiency, transparency of tobacco product application review process as part of FDA’s comprehensive framework to reduce tobacco-related disease and death

October 22, 2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s ongoing commitment to improving efficiency, transparency of tobacco product application review process as part of FDA’s comprehensive framework to reduce tobacco-related disease and death.

Statement by FDA Commissioner Scott Gottlieb, M.D., on FDA’s new steps to help produce farmers, processors more effectively comply with food safety requirements

October 19, 2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new steps to help produce farmers, fresh-cut produce processors more effectively comply with food safety requirements

Trump Administration Launches “Winning on Reducing Food Waste” Initiative

October 18, 2018

The U.S. Department of Agriculture (USDA), the U.S. Environmental Protection Agency (EPA), and the U.S. Food and Drug Administration (FDA) today announced the signing of a joint agency formal agreement under the “Winning on Reducing Food Waste” initiative.

FDA and DHS increase coordination of responses to medical device cybersecurity threats under new partnership; a part of the two agencies’ broader effort to protect patient safety

October 16, 2018

FDA and DHS announce partnership to address medical device cybersecurity threats

Statement by FDA Commissioner Scott Gottlieb, M.D., on FDA’s new steps to modernize drug development, improve efficiency and promote innovation of targeted therapies

October 15, 2018

FDA issues two guidance documents to provide drug developers greater clarity and direction as they pursue the next generation of therapies and treatments for patients.

FDA advances investigation into whether more than 40 e-cigarette products are being illegally marketed and outside agency’s compliance policy

October 12, 2018

FDA advances investigation into whether more than 40 e-cigarette products are being illegally marketed and outside agency’s compliance policy

FDA approves new DNA-based test to determine blood compatibility

October 11, 2018

FDA approves new DNA-based test to determine blood compatibility.Test is first of this type approved to report genotypes as final results

Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to advance the development of generic copies of complex drugs to improve patient access to medicines

October 9, 2018

FDA issued a new series of guidance documents that will advance the development of generic transdermal and topical delivery systems

Home | Copyright 2008-2024 FoodandDrugRecall.org